# DESWT-Pilot Study on the Safety of Myocardial Regeneration by Direct Epicardial Shock Wave Therapy in Combination With Coronary Artery Bypass Grafting

> **NCT00741065** · NA · UNKNOWN · sponsor: **Cardiac Regeneration Technologies, LLC** · enrollment: 10 (estimated)

## Conditions studied

- Reduced Left Ventricular Function Defined as LVEF < 50%
- Regional Left Ventricular Wall Motion Abnormalities

## Interventions

- **PROCEDURE:** Direct Epicardial Shock Wave Therapy

## Key facts

- **NCT ID:** NCT00741065
- **Lead sponsor:** Cardiac Regeneration Technologies, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2009-06
- **Final completion:** 2010-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2010-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00741065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00741065, "DESWT-Pilot Study on the Safety of Myocardial Regeneration by Direct Epicardial Shock Wave Therapy in Combination With Coronary Artery Bypass Grafting". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00741065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*